Amino-terminal fragment of urokinase-type plasminogen activator inhibits its plasminogen activation

Thrombosis Research

Volumn 106, Issue 2, 2002, Pages 105-111

  Sun, Ziyong ^a,b   Zhang, Pei Xiang ^a   Wang, Ping ^a,b   Gurewich, Victor ^b   Shen, Hai Yan ^a   Liu, Jian Ning ^a,c  

^a NANJING UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

Activation; Amino terminal fragment of urokinase; Plasmin; Plasminogen; Single chain urokinase; Two chain urokinase

Indexed keywords

[1 SERINE 135 LYSINE]; ARGININE; CARBOXYPEPTIDASE B[1 SERINE 135 LYSINE]; LYSINE; PEPTIDE DERIVATIVE; PLASMIN INHIBITOR; PLASMINOGEN; PLASMINOGEN[GLUTAMINE]; PLASMINOGEN[LYSINE]; UNCLASSIFIED DRUG; UROKINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING COMPETITION; CARBOXY TERMINAL SEQUENCE; DRUG EFFECT; ENZYME IMMOBILIZATION; IC 50; KRINGLE DOMAIN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING;

AMINO ACID SUBSTITUTION; ANIMALS; BINDING, COMPETITIVE; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; KINETICS; KRINGLES; MAMMALS; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; PLASMIN; PLASMINOGEN; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0037089065     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00091-9     Document Type: Article

References (26)

1. Gunzler W.A., Steffens G.J., Otting F., Kim S.M.A., Frankus E., Flohe L. The primary structure of high molecular weight urokinase from human urine. Hoppe-Seyler Z. Physiol. Chem. 363:1982;1155-1165.
2. Li C., Gurewich V., Liu J.N. Urokinase-type plasminogen activator-induced monocyte adhesion is modulated by kininogen, kallikrein, factor XII, and plasminogen. Exp. Cell Res. 226:1996;239-242.
3. Yebra M., Goretzki L., Pfeifer M., Mueller B.M. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration enhancing integrin-mediated signal transduction. Exp. Cell Res. 250:1999;231-240.
4. Resnati M., Guttinger M., Valcamonica S., Sidenius N., Blasi F., Fazioli F. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J. 15:1996;1572-1582.
5. Rabbani S.A., Mazar A.P., Bernier S.M., Haq M., Bolivar L., Henkin J.et al. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J. Biol. Chem. 267:1992;14151-14156.
6. Fischer K., Lutz V., Wilhelm O., Schmitt M., Graeff H., Heiss P.et al. Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function. FEBS Lett. 438:1998;101-105.
7. Mukhina S., Stepanova V., Traktouev D., Poliakov A., Beabealashvilly R., Gursky Y.et al. The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. J. Biol. Chem. 275:2000;16450-16458.
8. Gurewich V., Pannell R., Louie S., Kelley P., Suddith R.L., Greenlee R. Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). J. Clin. Invest. 73:1984;1731-1739.
9. Ronne E., Behrendt N., Ellis V., Ploug M., Dano K., Hoyer-Hansen G. Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the Nh2-terminal domain of the urokinase receptor. FEBS Lett. 288:1991;233-236.
10. Moscaatelli D., Rifkin D.B. Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochim. Biophys. Acta. 948:1988;67-85.
11. Sappino A.P., Huarte J., Belin D., Vassalli J.D. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos. J. Cell Biol. 109:1989;2471-2479.
12. Andreasen P.A., Kjoller L., Christensen L., Duffy M. The urokinase-type plasminogen activator system in cancer metastasis. Int. J. Cancer. 72:1997;1-22.
13. Lucas M., Straight D.L., Fretto L.J., McKee P.A. The effect of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity. J. Biol. Chem. 258:1983;12171-12177.
14. Urano T., Sator, de Serrano V.S., Gaffney P.J., Castellino F.J. The activation of human [Glu]plasminogen by human single-chain urokinase. Arch. Biochem. Biophys. 264:1988;222-230.
15. Christensen U. Urokinase-catalysed plasminogen activation, effects of ligands binding to the AH-site of plasminogen. Biochim. Biophys. Acta. 95:1988;258-265.
16. Liu J., Gurewich V. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin. J. Clin. Invest. 88:1991;2012-2017.
17. Kolev K., Owen W.G., Machovich R. Dual effect of synthetic plasmin substrates on plasminogen activation. Biochim. Biophys. Acta. 1247:1995;239-245.
18. Higazi A.A.R., Cines D. Regulation of single chain urokinase by small peptides. Thromb. Res. 84:1996;243-252.
19. Ellis V., Whawell S.A., Werner F., Deadman J.J. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen. Biochemistry. 38:1999;651-659.
20. Sun Z., Liu B.F., Chen Y., Gurewich V., Zhu D., Liu J.N. Analysis of the forces which stabilize the active conformation of urokinase-type plasminogen activator. Biochemistry. 37:1998;2935-2940.
21. Stoppelli M.P., Corti A., Soffientini A., Cassani G., Blasi F., Assoian R.K. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc. Natl. Acad Sci. 82:1985;4939-4943.
22. Lenich C., Pannell R., Gurewich V. The effect of the carboxy-terminal lysine of urokinase on the catalysis of plasminogen activation. Thromb. Res. 64:1991;69-80.
23. Castellino F.J., Powell J.R. Human plasminogen. Methods Enzymol. 80:1981;365-378.
24. Sottrup-Jensen L., Claeys H., Zajdel M., Petersen T.E., Magnusson S. The primary structure of human plasminogen: isolation of two lysine-binding fragments and one mini-plasminogen (MW. 38,000) by elastase-catalyzed-specific limited proteolysis. Prog. Chem. Fibrinolysis Thrombolysis. 3:1978;191-209.
25. Liu J.N., Gurewich V. The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator. Blood. 81:1993;980-987.
26. Petersen L.C. Kinetics of reciprocal pro-urokinase/plasminogen activation: stimulation by a template formed by the urokinase receptor bound to poly(D-lysine). Eur. J. Biochem. 245:1997;316-323.